Alex W.

Alex W. Email and Phone Number

Senior Healthcare and Pharmaceutical Start-Up Executive | Business Development | Compliance (SOX) | Financial Planning and Analysis (FP&A) | M&A | Operations Management | PBM | Product Management | Sales | Team Building @ PrudentRx
Alex W.'s Location
Cary, North Carolina, United States, United States
Alex W.'s Contact Details

Alex W. work email

Alex W. personal email

Alex W. phone numbers

About Alex W.

I am a senior healthcare and pharmaceutical start-up executive with more than 25 years of experience. I have worked for nine healthcare and pharmaceutical start-ups that research, manufacture, license, price, and distribute drugs, diagnostic tests, and medical devices.I currently work as the CFO for PrudentRX, a pharmacy benefit management (PBM) partner. I previously worked as the Head of U.S. Finance and Operations for InflaRx Pharmaceuticals, Inc., as the Vice President of Finance for Proliant Health & Biologics, LLC, and as the Senior Director of Commercial Operations for RedHill Biopharma, LTD.I have extensive experience directing all daily operations, including those involving accounting, budgeting, compliance, contracts, data analysis and reporting, distribution, financial planning and analysis (FP&A), licensing, market research, mergers and acquisitions, product development and launches, sales, and supply chain management. I build, lead, and mentor large teams. I also work with boards of directors, senior executives, department heads, external partners, investment bankers, and stakeholders.The following highlights from my profile demonstrate my success in directing and managing healthcare and pharmaceutical start-ups:• Led the acquisition of Boval BioSolutions and Desert Biologicals by Proliant Health & Biologicals, LLC. Renegotiated and reduced the price(25% reduction) for Boval Biosolutions, even though the original price had already been finalized.• Significantly reduced accounts receivable as a percentage of revenues in my first year at Entera Health.• Transitioned EnteraGam® to RedHill Biopharma, where I was the Senior Director of Commercial Operations.• Managed the in-licensing of Atrantil® and the out-licensing of EnteraGam® at Entera Health.• Helped develop strategic plans for Numera™ and the NMR LipoProfile test at LipoScience, Inc. Wrote the Numera™ marketing plan.I received my MBA from Penn State University, and my B.S. in Business Administration with a concentration in Management Information Systems, from The Citadel. I graduated with honors from The Citadel, where I was an All-American Scholar. I am also fluent in German.Please connect with me to learn how my skills and experience can help you and your organization. You can also contact me at awalden01@gmail.com.

Alex W.'s Current Company Details
PrudentRx

Prudentrx

View
Senior Healthcare and Pharmaceutical Start-Up Executive | Business Development | Compliance (SOX) | Financial Planning and Analysis (FP&A) | M&A | Operations Management | PBM | Product Management | Sales | Team Building
Alex W. Work Experience Details
  • Prudentrx
    Chief Financial Officer
    Prudentrx Feb 2022 - Present
    Tampa, Fl, Us
    View
  • Inflarx N.V.
    Vice President Of Finance And Operations
    Inflarx N.V. Aug 2020 - Feb 2022
    Jena, De
    InflaRx is a German biotech company with a U.S. subsidiary that develops “pioneering anti-inflammatory therapeutics.” • Directed the daily operations of the U.S. subsidiary, including FP&A, human resources, and IT.• Managed the non-research related operations of the U.S subsidiary.
    View
  • Proliant Health & Biologics, Llc
    Vice President Of Finance (Report To The Ceos Of Ph&B And The Cfo Of Lgi)
    Proliant Health & Biologics, Llc Jun 2018 - Aug 2020
    Proliant Health & Biologicals and Entera Health are part of the Lauridsen Group, Inc. (LGI). Entera Health promoted a prescription medical food to U.S. gastroenterologists and Proliant marketed bovine serum albumen worldwide. Proliant had approximately 75 employees and $15 million in annual revenues.• Directed the daily financial operations of both companies, including FP&A. (My daily job duties were the same as those described in my previous position with Entera Health.)• Led the acquisition of Boval BioSolutions and Desert Biologicals by Proliant in 2019.
  • Redhill Biopharma Ltd.
    Sr. Director Commercial Operations
    Redhill Biopharma Ltd. Jul 2017 - Jun 2018
    Raleigh, Nc, Us
    RedHill (RDHL) is a publicly traded “specialty biopharmaceutical company primarily focused on development and commercialization of clinical late-stage, proprietary drugs for the treatment of gastrointestinal diseases.” • Directed all trade and general commercial operations. Transitioned commercial operations from Entera Health to RedHill, including: (1) transitioning EnteraGam® to RedHill, and (2) establishing a trade channel at RedHill.• Developed strategic plans for product lines, including analyzing prescriber trends, prescription trends, and voucher performance.
    View
  • Entera Health
    Vp Finance; Director Of Finance
    Entera Health Jun 2013 - Jul 2017
    Ankeny, Iowa, Us
    At the time, the company was run as Entera Health, which promoted EnteraGam® to gastroenterologists. The company had approximately 50 employees and $12 million in annual revenues.Board of Directors• Prepared and presented quarterly financial reports to the board of directors.• Acted as a liaison between the commercial business team and the board of directors.• Created an outside board to advise the board of directors.Commercial Analytics• Negotiated managed care contracts with pharmacy benefit managers and managed care organizations.• Established sampling policies, incentive compensation plans, and expense guidelines.• Established territories and call patterns. Managed white space and vehicle fleets.Financial Planning and Analysis• Directed all daily FP&A operations, including accounts payable, accounts receivable, audits, budgets, and close outs.• Established a contract management system. Reviewed and approved all contracts.• Developed KPIs for the monthly reports presented to the advisory board, the board of directors, and the executive team.• Managed the finances of all research and development projects.Operations Management• Supervised state licensing processes. Managed the in-licensing of Atrantil® and the out-licensing of EnteraGam®.• Managed due diligence and strategic planning processes, including the integration of products.• Established and ran weekly “Top Line” meetings to discuss projects and allocate resources among departments.Supply Chain Management• Managed inventory, including tracking.• Managed all third-party logistics (3PL), including relationships with manufacturers.
    View
  • Cornerstone Therapeutics
    Manager, Fp&A
    Cornerstone Therapeutics Feb 2008 - Jun 2013
    Cary, North Carolina, Us
    Cornerstone Therapeutics (CRTX) was “a specialty pharmaceutical company, engaged in the acquisition, development, and commercialization of branded and generic pharmaceuticals for the respiratory and related markets.”• Chairman of the Pricing Committee.• Provided financial summaries to executives.• Analyzed current and prospective company and product acquisitions. Made presentations to the board of directors.• Speaker at Financial Planning and Analysis (FP&A) conferences about object based financial modeling.Financial Planning and Analysis• Managed the entire budget and planning process.• Analyzed returns. Calculated returns on investments and tracked profitability (historical and projected).• Tracked monthly expense variance, weekly cash balance, and outstanding channel inventory.• Built dashboard with KPI’s that guided daily and weekly operating activities.• Implemented Whitebirch software to increase analysis capabilities, and the accuracy of the underlying data.• Projected cash flow. Worked with senior management to manage cash on hand.• Worked with marketing teams on naming, product life-cycle planning, and Key Opinion Leader (KOL) seminars.Compliance• Reviewed management discussion and analysis (MDA) for Form 10-K and Form 10-Q reporting.• Ensured compliance with GAAP and Sarbanes-Oxley (SOX). Managed monthly SOX procedure.
    View
  • Liposcience, Inc
    Associate Product Manager
    Liposcience, Inc Apr 2005 - Nov 2007
    LipoScience developed proprietary diagnostic tests to address a broad range of metabolic and other diseases, including the risk of heart disease.• Created a new message, promotional material, and product positioning for the Clinical Analyzer test. Trained sales representatives on the message and product positioning.• Managed clinical symposia and round table discussions.• Developed a pricing model and forecast for a ‘First-in-Class’ medical device.• Helped develop strategic plans for Numera™ and the NMR LipoProfile test. Wrote the Numera™ marketing plan.• Implemented a new collection device with distribution partners.• Conducted primary market research for the target physician population.
  • Mylan Bertek
    Contract Rebate Analyst
    Mylan Bertek Jul 2003 - Apr 2005
    • Established a performance tracking system that measured the profitability of managed care customers.• Evaluated the profitability of product lines and customers based on contract structure.• Calculated the impact of price increases and decreases to ensure profitability.• Designed systems that monitored rebate payments to ensure their accuracy. Recovered about $600,000 in rebates.• Established systems that improved the efficiency and profitability of the pricing and contracts department by increasing the number of metrics it measures.Associate Market Research Analyst• Evaluated the market potential of compounds and companies (foreign and domestic).• Forecasted all Mylan Bertek product sales. Changed the forecasting process to increase its accuracy.• Supported business development and marketing.
  • Aaipharma
    Market Research Analyst
    Aaipharma Jun 2000 - Jun 2003
    Wilmington, Nc, Us
    AAIPharma Services Corp./Cambridge Major Laboratories, Inc., changed its name to Alcami in 2016. The two companies originally combined in 2013. Alcami is “a leading provider of custom development and manufacturing services for the pharmaceutical and biotechnology industries.” It offers “analytical testing and development services for active pharmaceutical ingredients (APIs) with oral solid and parenteral dose finished product capacity.”Market Research Analyst• Built forecasting models for Aquasol D, Brethine, and Azasan.• Researched pharmaceuticals and evaluated their market potential. Worked with senior executives to develop and implement U.S. and international market forecasting models.• Collated and summarized pharmaceutical data into research reports.• Primary source of market research data for product management, business development, and Japanese JV.Associate Product Manager (Darvon/Darvon-N)• Managed the promotion of Darvon and Darvocet-N.• Created and implemented a sales tracking and performance system.• Used internal research and development expertise to manage product life cycles, prolong brand life, and counteract generic cannibalization.• Developed and administered nationwide focus group research.Interim Product Manager (Brethine)• Wrote the marketing plan and implemented promotional strategies for Brethine. • Trained sales representatives and interns.Marketing Associate• Analyzed product performance for senior management, including providing advice about acquisition decisions.• Compiled databases and resources. Created a pharma market research department.
    View

Alex W. Skills

Product Marketing Variance Analysis Cost Planning International Public Speaking Balance Sheet Review Mergers Cardiology Dermatology Sales Gastroenterology Neurology Operating Budgets Start Ups Pulmonology Forecasting Biotechnology Business Development Market Research English Healthcare Competitive Analysis Finance Budget Reconciliation Investor Relations Life Sciences Medical Devices Strategic Planning Balance Sheet Hospital Sales Business Planning Cash Flow Forecasting Lifesciences Cross Functional Team Leadership Product Management Income Statement Budget Process Market Analysis Mba Corporate Fp&a Management Financial Reporting Product Development Product Launch Pharmaceutical Industry Revenue Forecasting German Pharmaceutical Sales Mergers And Acquisitions Commercialization

Alex W. Education Details

  • Penn State University
    Penn State University
    Business Administration
  • The Citadel
    The Citadel
    Business Administration

Frequently Asked Questions about Alex W.

What company does Alex W. work for?

Alex W. works for Prudentrx

What is Alex W.'s role at the current company?

Alex W.'s current role is Senior Healthcare and Pharmaceutical Start-Up Executive | Business Development | Compliance (SOX) | Financial Planning and Analysis (FP&A) | M&A | Operations Management | PBM | Product Management | Sales | Team Building.

What is Alex W.'s email address?

Alex W.'s email address is aw****@****ail.com

What is Alex W.'s direct phone number?

Alex W.'s direct phone number is (855) 436*****

What schools did Alex W. attend?

Alex W. attended Penn State University, The Citadel.

What skills is Alex W. known for?

Alex W. has skills like Product Marketing, Variance Analysis, Cost Planning, International, Public Speaking, Balance Sheet Review, Mergers, Cardiology, Dermatology, Sales, Gastroenterology, Neurology.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.